A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects

NCT03363815 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Heathy Volunteer

Interventions

DRUG: CC-90001
DRUG: Omeprazole
DRUG: Midazolam
DRUG: Warfarin
DIETARY_SUPPLEMENT: Vitamin K
DRUG: Rosuvastatin
DRUG: Metformin
DRUG: Digoxin
DRUG: Nintedanib

Sponsor

Celgene